A grade PMID 42321916
View analysis →Finding therapies hidden in 39,079 pediatric cancer papers.
Neurocompute scores pediatric oncology literature, surfaces overlooked therapeutic signals, and turns fragmented childhood cancer research into a living discovery terminal.
Ranked Discovery Journal Articles
A grade PMID 42690647
View analysis →A grade PMID 42372741
View analysis →A grade PMID 42216567
View analysis →A grade PMID 41916649
View analysis →A grade PMID 42382416
View analysis →A grade PMID 42150584
View analysis →B grade PMID 42748428
View analysis →A grade PMID 41756844
View analysis →A grade PMID 42765973
View analysis →A grade PMID 42362103
View analysis →A grade PMID 42101908
View analysis →Database feed
All ranked pediatric cancer papers
This pathology-registry study describes age- and sex-specific cancer frequencies in Balochistan from 2021–2024, finding gastrointestinal cancers prominent in adults and brain tumours and lymphomas predominant among the combined younger groups.
The evidence supports regional cancer-surveillance and control planning rather than a specific therapy; it may justify further investigation of local exposures and pediatric diagnostic needs, but environmental causation and any resulting preventive or therapeutic strategy remain inferential.
This retrospective cohort describes staging, treatment trajectories, and survival among 134 adults with hepatocellular carcinoma managed in a structured multidisciplinary center in Colombia, where most patients had early-stage disease and received locoregional therapy.
The evidence shows favorable survival estimates and frequent early-stage diagnosis within this adult center-of-excellence cohort; it only suggests, but does not establish, that structured multidisciplinary care could improve timely diagnosis, treatment access, or outcomes, and the record provides no pediatric-specific evidence.
In a 17-patient retrospective series spanning ages 5–80 years, an 18 MHz color Doppler ultrasound probe characterized blood flow in preorbital masses better than an 11 MHz probe and more clearly differentiated pathology-confirmed benign from malignant lesions.
The evidence supports a diagnostic—not therapeutic—signal: higher-frequency color Doppler may improve preoperative classification of preorbital masses; it can only be inferred, pending larger pediatric-specific validation, that better classification could guide biopsy, surgery, or referral and thereby reduce diagnostic delay or unnecessary intervention.
This phenomenological study of 17 relatives aged 6–23 years of hospice patients dying from cancer in Denmark found that young relatives navigate existential uncertainty through a reciprocal balancing process shaped by opportunities to be themselves and by authentic, appropriately aligned communication and care.
The study provides qualitative evidence about unmet existential and communication needs but does not test a therapy; it supports the inference that developmentally tailored communication, recognition, and protected spaces for young relatives could improve psychosocial or bereavement support, which would require prospective intervention testing.
This qualitative analysis of two caregiver-authored pediatric cancer blogs reports that praise shifts over time from process-focused coping language toward heroic, communal, and elegiac identity framing during treatment, crisis, and loss.
The study provides descriptive evidence about changing praise and identity language; it does not test an intervention, but it suggests the hypothesis that balanced, process-centered, emotionally honest praise could improve psychosocial support by preserving space for fear, ambivalence, and a child's ordinary identity.
In a cross-sectional cohort of 124 pediatric brain tumor patients assessed an average of 14.15 months after diagnosis, mean social functioning was generally within the population-average range, while leisure functioning was modestly lower and poorer outcomes were associated with older age at diagnosis or male sex, but not with family psychosocial risk or other medical factors.
The study does not establish a therapeutic target; it suggests, as an inference for future testing, that early psychosocial monitoring or interventions focused on leisure participation and on potentially vulnerable demographic groups could be explored, while alternative family factors such as coping or family dynamics may be more actionable than the measured aggregate psychosocial-risk score.
In 130 patients with endometrial carcinoma, a nomogram combining age, Ki-67 index, and lymphocyte-to-monocyte ratio predicted postoperative high-risk classification with a training AUC of 0.904 and a 23-patient validation-set AUC of 0.846.
The study provides evidence that three preoperative or tissue-associated variables can predict pathological risk classification; it is only an inference that this model could improve treatment planning or outcomes, because treatment selection, survival benefit, toxicity reduction, and prospective clinical utility were not evaluated.
This GRADE-based Latin American guideline provides regionally adapted recommendations for psoriasis treatment, including pediatric psoriasis and unspecified special considerations for patients with cancer.
Evidence: the guideline offers clinically actionable psoriasis treatment pathways and addresses pediatric psoriasis and cancer as special situations; inference: it might inform management of psoriasis in selected pediatric oncology patients, but the supplied record provides no cancer-specific recommendations, oncology outcomes, or evidence for an anticancer intervention.
In a retrospective cohort of 78 treatment-naïve patients with predominantly early-stage, single-lesion hepatocellular carcinoma, choline PET/CT metrics were associated with overall survival only in univariate analyses and added no independent prognostic value beyond MRI or FDG PET/CT after adjustment.
Evidence: MRI-derived tumor volume, but not choline PET-derived measures, remained independently prognostic after adjustment, while treatment modality was the strongest prognostic factor. Inference: avoiding routine choline PET/CT when MRI and FDG PET/CT are available might reduce unnecessary imaging burden or cost, but this record does not test imaging-guided treatment selection, clinical utility, or any pediatric population.
This GBD 2021 observational analysis reports declining age-standardized leukemia mortality but rising absolute deaths across Asia from 1992 to 2021, with high early-childhood mortality, regional disparities, and a predominance of ALL-related deaths in East Asia.
The evidence identifies geographic, age-related, and leukemia-subtype mortality patterns; as an inference requiring prospective evaluation, expanding pediatric hematology access, diagnostic and referral capacity, and risk-stratified ALL treatment in high-burden regions could reduce preventable childhood leukemia deaths.
Population-based EUROCARE-6 and SEER analyses found approximately 84% overall 5-year relative survival among patients aged 15-39 years, region- and cancer-specific survival differences, improving survival over time, and rising incidence in both Europe and the United States during the studied periods.
The evidence identifies CNS tumours and other cancer-specific regional survival gaps as priorities for investigation; it can be inferred—but is not demonstrated—that comparing treatment delivery, access, prevention, and supportive-care practices across regions could reveal strategies to improve outcomes.
The paper reports a standardized dataset of 642 non-enhanced CT scans spanning six pediatric extracranial germ cell tumor subtypes, with expert-annotated tumor masks and preliminary radiomics-based machine-learning experiments for differential diagnosis.
The record supports the dataset's potential for developing subtype-classification tools; it is an untested inference that improved preoperative classification could eventually guide treatment selection or reduce inappropriate interventions, as no therapeutic decisions or patient outcomes were evaluated.